Journal
MOLECULAR SYSTEMS BIOLOGY
Volume 15, Issue 8, Pages -Publisher
WILEY
DOI: 10.15252/msb.20198828
Keywords
endothelin; GPCR; melanoma; molecular modelling; phosphoproteomics
Categories
Funding
- Idorsia Pharmaceuticals
- European Union [675585]
- ERC [670821]
- Swiss National Science Foundation [3100A0-688107679]
- Innovative Medicines Initiative project ULTRA-DD (FP07/2007-2013) [115766]
- European Research Council (ERC) [670821] Funding Source: European Research Council (ERC)
Ask authors/readers for more resources
Endothelins (EDN) are peptide hormones that activate a GPCR signalling system and contribute to several diseases, including hypertension and cancer. Current knowledge about EDN signalling is fragmentary, and no systems level understanding is available. We investigated phosphoproteomic changes caused by endothelin B receptor (ENDRB) activation in the melanoma cell lines UACC257 and A2058 and built an integrated model of EDNRB signalling from the phosphoproteomics data. More than 5,000 unique phosphopeptides were quantified. EDN induced quantitative changes in more than 800 phosphopeptides, which were all strictly dependent on EDNRB. Activated kinases were identified based on high confidence EDN target sites and validated by Western blot. The data were combined with prior knowledge to construct the first comprehensive logic model of EDN signalling. Among the kinases predicted by the signalling model, AKT, JNK, PKC and AMP could be functionally linked to EDN-induced cell migration. The model contributes to the system-level understanding of the mechanisms underlying the pleiotropic effects of EDN signalling and supports the rational selection of kinase inhibitors for combination treatments with EDN receptor antagonists.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available